WebSimilarly, SUP-M2 cells were also sensitive to AZD1480 treatment, and both p-STAT3 and cell proliferation were markedly inhibited (fig. S7A, right panel). Finally, we evaluated the effect of STAT3 inhibition by a drug, crizotinib, an inhibitor of the upstream kinase ALK . As expected, treatment of KARPAS299 and SUP-M2 cells with crizotinib ... WebDec 31, 2024 · STAT3 and its targeting inhibitors in osteosarcoma Yun Liu,1 ,2 ,3 Shijie Liao,2 ,3 ,4 Samuel Bennett,2 Haijun Tang,5 Dezhi Song,2 ,3 David Wood,2 Xinli Zhan,1 …
Targeted inhibition of STAT3 as a potential treatment …
WebDec 5, 2013 · One chemical library with 920,000 small drug-like compounds virtually screened by docking each into the peptide-binding pocket of the STAT3-SH2 domain, the compounds C3, C30, and C188 were found to be active in inhibiting IL-6-mediated phosphorylation of STAT3 with an IC 50 of 91, 18 and 73 μM respectively [].As C188 … WebJan 7, 2024 · By evaluating CABE, Priebe detected novel compounds that could enhance the ability to inhibit p-STAT3. WP1066 was eventually identified as a lead compound … ruth whaley obituary
A Tumor Microenvironment-Driven Network Regulated by STAT3 …
WebBrian Druker and Nick Lydon of Novartis took up the challenge of developing Bcr-Abl inhibitors as cancer drugs (21, 22). The result was imatinib (Gleevec), the first TKI to be approved for the clinic. ... Until NT157, all STAT3 inhibitors targeted either the dimerization of phosphorylated STAT3 or the binding of the activated STAT3 dimer to DNA. WebJan 8, 2024 · Fig. 2: N4 inhibits STAT3 activation in pancreatic cancer cells. A PANC-1, CAPAN-2, and BXPC-3 cells were treated with the indicated concentrations of N4 for 24 h. Then, p-STAT3 (Y705),... WebSince the first peptide inhibitor of STAT3, PY*LKTK (where Y* represents phosphotyrosine) was reported, 151 a number of small molecules have been developed to inhibit directly … is chess creative